Skip to main content
Caplight Logo









STANT

STANT

Private
OssHealthcare & Life Scienceshttps://stant-biotech.com/

Last Round

Seed

Nov 19, 2024

Company Overview

STANT operates in Healthcare & Life Sciences and is based in Oss. Its latest recorded funding round was a Seed round in November 2024.

STANT is a biotechnology company developing proprietary inhibitors of the STING pathway for the treatment of autoimmune, inflammatory, cardiovascular, metabolic, and neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

STANT Comparables

Compare STANT with similar companies based on industry and business-model similarity.

STANT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iSD Immunotech
86%
ImmuneSensor Therapeutics
79%
IFM Therapeutics
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

STANT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 19, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

STANT Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 19, 2024

    Seed round with participation from First Fund and Brabantse Ontwikkelings Maatschappij.

Book a demo to see all signals

For institutional investors. Book with your work email.

STANT Filings

Explore SEC and related filing metadata, where available.

STANT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about STANT's valuation, stock price, and market status.

Is STANT a public or private company?

STANT is a private company.

What is the current stock price of STANT?

STANT is a private company, so its shares have no public market price. Caplight tracks STANT's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is STANT worth (valuation)?

Valuation information for STANT is not publicly available.

Can I buy STANT stock?

STANT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was STANT's last funding round?

STANT's most recent funding round was Seed on November 19, 2024.

Who are the main investors in STANT?

Key investors in STANT include Brabantse Ontwikkelings Maatschappij, Brabantse Ontwikkelings Maatschappij, First Fund.

Will STANT IPO soon?

No public IPO plans have been announced for STANT.

How can I track STANT secondary market activity?

Caplight tracks bids, offers, and trades in STANT's shares on secondary markets.

Firmographic Details

HeadquartersOss
Employee Range2
Year Founded2024
Last FundingNov 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?